Racial Disparities ID’d in Autosomal Dominant Polycystic Kidney Disease

TUESDAY, July 12, 2022 (HealthDay News) -- Black and Hispanic patients with autosomal dominant polycystic kidney disease (ADPKD) reach kidney failure earlier than White patients and are less likely to receive a kidney transplant preemptively and after initiating dialysis, according to a study published in the July issue of the Clinical Journal of the American Society of Nephrology.
Rita L. McGill, M.D., from the University of Chicago, and colleagues examined the impact of health disparities on outcomes in ADPKD in a retrospective cohort analysis of adults with ADPKD in the U.S. Renal Data System from January 2000 to June 2018. Data were included for 41,485 ADPKD patients who were followed for a median of 25 months.
The researchers found that for Black, Hispanic, and White patients, the mean age at kidney failure was 55, 53, and 57 years, respectively. For preemptive transplant, the odds ratios were 0.33 and 0.50 for Black and Hispanic patients, respectively, versus White patients. For transplant after initiation of dialysis, the corresponding odds ratios were 0.61 and 0.78.
"We discovered that progression to kidney failure occurred earlier in Black and Hispanic patients with ADPKD, and that access to transplantation was less than in White patients, both before and after the onset of dialysis treatment," McGill said in a statement. "Our results suggest that there is potential to improve kidney care and kidney transplantation for Black and Hispanic patients."
One author disclosed financial ties to the pharmaceutical industry.
Related Posts
La apnea del sueño en la niñez podría afectar al cerebro en desarrollo
LUNES, 27 de marzo de 2023 (HealthDay News) -- Los adolescentes con apnea del...
Risk for VTE Up During Five Years After Prostate Cancer Diagnosis
TUESDAY, May 24, 2022 (HealthDay News) -- Men with prostate cancer have an...
La vacuna Jynneos protege de la viruela del simio, según datos iniciales de EE. UU.
MIÉRCOLES, 29 de septiembre de 2022 (HealthDay News) -- La vacuna Jynneos, que...
Un panel de la FDA votará sobre la primera vacuna contra el VSR en el embarazo para proteger a los bebés
JUEVES, 18 de mayo de 2023 (HealthDay News) -- Un panel de asesores de la...
